Nearly 3 months after the FDA green-lit the TTR stabilizer, it joins tafamidis as the second therapy in Europe for the ...

The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

The recently approved device simplifies operator manipulations by loading a balloon and filter onto the stent.

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...

Each fire’s impact could depend on what was burning, for how long, and levels of public awareness, researchers hypothesize.

More than 50% survived to discharge, which investigators attribute to high rates of bystander-initiated CPR and AED use.

Not everyone agrees: one expert says it would be more helpful to consider imaging as a quality measure at the local level.

Overall complication rates were similar to those seen with transfemoral access, however, and patients liked it better.

Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant ...